MCID: VRL012
MIFTS: 50

Viral Meningitis malady

Categories: Infectious diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Viral Meningitis

Aliases & Descriptions for Viral Meningitis:

Name: Viral Meningitis 12 3 14 69
Meningitis, Viral 42
Meningitis Viral 52

Classifications:



Summaries for Viral Meningitis

CDC : 3 Español: Meningitis viral

MalaCards based summary : Viral Meningitis, also known as meningitis, viral, is related to meningitis and mollaret meningitis. An important gene associated with Viral Meningitis is SERPINA1 (Serpin Family A Member 1), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Efavirenz and Lamivudine have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and t cells, and related phenotypes are hematopoietic system and immune system

Wikipedia : 71 Viral meningitis is a type of meningitis due to a viral infection. It results in inflammation of the... more...

Related Diseases for Viral Meningitis

Diseases in the Meningitis family:

Viral Meningitis Chronic Meningitis
Bacterial Meningitis

Diseases related to Viral Meningitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 166)
id Related Disease Score Top Affiliating Genes
1 meningitis 11.4
2 mollaret meningitis 10.8
3 lymphocytic choriomeningitis 10.5
4 israeli tick typhus 10.2 CCL5 IFNG
5 eating seizures 10.2 CCL5 IL16
6 vps11-related autosomal recessive hypomyelinating leukodystrophy 10.2 CCL5 IL6
7 retinal ischemia 10.2 CCL2 CCL5 IFNG
8 deafness, autosomal recessive 67 10.2 CCL2 CCL5 IFNG
9 lipid storage disease 10.2 CCL5 IFNG IL16
10 coloboma of iris 10.1 CRP IL6
11 hyperlucent lung 10.1 CCL2 CRP IFNG
12 steroid dehydrogenase deficiency dental anomalies 10.1 CCL2 CCL5 IL6
13 smooth muscle tumor 10.1 CCL2 CCL5 IL6
14 causalgia 10.1 CCL5 IFNG IL6
15 mansonelliasis 10.1 CCL5 IFNG IL6
16 immune-complex glomerulonephritis 10.1 CCL2 IFNG IL6
17 cutaneous sclerosis 10.1 CRP IL6
18 oral cavity carcinoma in situ 10.1 ADA CCL2 IFNG
19 shoulder impingement syndrome 10.1 CRP IL6
20 eating disorder 10.1 CCL2 CRP SERPINA1
21 anus leiomyosarcoma 10.1 CCL5 IFNG IL6
22 pulpitis 10.1 CCL5 CXCL10 IFNG
23 unilateral multicystic dysplastic kidney 10.1 CRP IL6
24 viral infectious disease 10.1
25 encephalitis 10.1
26 myeloid proliferations related to down syndrome 10.1 CD14 CXCL8
27 cutaneous candidiasis 10.1 CCL2 CXCL8
28 proximal symphalangism 10.1 CCL2 CXCL10 IFNG
29 cataract, total congenital 10.1 CRP IFNG IL6
30 hemangioma of spleen 10.1 CRP IFNG IL6
31 multiple mitochondrial dysfunctions syndrome 10.1 CRP IFNG IL6
32 hypertropia 10.1 ADA CRP IFNG
33 plummer's disease 10.1 CRP IFNG IL6
34 follicular adenoma 10.1 CRP IFNG IL6
35 rift valley fever 10.1 CRP IFNG IL6
36 neutrophilia, hereditary 10.0 CRP IL6
37 focal dystonia 10.0 CCL2 CRP IL6
38 mixed ductal-endocrine carcinoma 10.0 CCL2 IL6 TIMP2
39 esophageal candidiasis 10.0 CCL2 CXCL10 IFNG
40 myoclonic astatic epilepsy 10.0 CD14 CXCL8
41 plantar fasciitis 10.0 CCL2 CCL5 CXCL10
42 anterior foramen magnum meningioma 10.0 ADA IFNG IL6
43 hyperuricemia, pulmonary hypertension, renal failure, and alkalosis 10.0 CCL2 CRP IL6
44 idiopathic peripheral autonomic neuropathy 10.0 ADA SERPINA1
45 neonatal jaundice 10.0 CCL2 CCL5 IFNG IL6
46 hidradenitis suppurativa 10.0 CCL5 CXCL8
47 adrenal adenoma 10.0 CCL2 CRP IL6
48 villonodular synovitis 10.0 ADA CRP
49 calcinosis 10.0 CCL2 CRP IL6
50 choanal atresia, bilateral 10.0 CCL2 CXCL10 IL6

Comorbidity relations with Viral Meningitis via Phenotypic Disease Network (PDN):


Acute Cystitis Hypertension, Essential

Graphical network of the top 20 diseases related to Viral Meningitis:



Diseases related to Viral Meningitis

Symptoms & Phenotypes for Viral Meningitis

MGI Mouse Phenotypes related to Viral Meningitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.56 TIMP2 ADA CCL5 CD14 CXCL10 IFNG
2 immune system MP:0005387 9.32 ADA CCL2 CCL5 CD14 CRP CXCL10

Drugs & Therapeutics for Viral Meningitis

Drugs for Viral Meningitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 175)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Efavirenz Approved, Investigational Phase 4,Phase 2,Phase 3 154598-52-4 64139
2
Lamivudine Approved, Investigational Phase 4,Phase 2,Phase 3 134678-17-4 60825
3
Zidovudine Approved Phase 4 30516-87-1 35370
4
Stavudine Approved, Investigational Phase 4,Phase 2,Phase 3 3056-17-5 18283
5
Amphotericin B Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 1397-89-3 14956 5280965
6
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
7
Sulfamethoxazole Approved Phase 4 723-46-6 5329
8
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
9
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
10
leucovorin Approved, Nutraceutical Phase 4 58-05-9 54575, 6560146 143
11 Anti-HIV Agents Phase 4,Phase 2,Phase 3
12 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1
13 Anti-Retroviral Agents Phase 4,Phase 2,Phase 3
14 Antiviral Agents Phase 4,Phase 2,Phase 3
15 Cytochrome P-450 CYP2C9 Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
16 Cytochrome P-450 CYP3A Inducers Phase 4,Phase 2,Phase 3
17 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
18 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3
19 Reverse Transcriptase Inhibitors Phase 4,Phase 2,Phase 3
20 Antibodies Phase 4,Phase 3,Phase 1,Phase 2
21 Immunoglobulins Phase 4,Phase 3,Phase 1,Phase 2
22 Vaccines Phase 4,Phase 3,Phase 2,Phase 1
23 Heptavalent Pneumococcal Conjugate Vaccine Phase 4,Phase 3,Phase 2
24 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Phase 1
25 Antiparasitic Agents Phase 4,Phase 3,Phase 2,Phase 1
26 Antiprotozoal Agents Phase 4,Phase 3,Phase 2,Phase 1
27 Antifungal Agents Phase 4,Phase 3,Phase 2,Phase 1
28 Liposomal amphotericin B Phase 4,Phase 3,Phase 2,Phase 1
29 Antimalarials Phase 4,Phase 2
30 Folic Acid Antagonists Phase 4
31 Renal Agents Phase 4
32 Trimethoprim, Sulfamethoxazole Drug Combination Phase 4
33 Vitamin B Complex Phase 4
34 Folate Nutraceutical Phase 4
35 Vitamin B9 Nutraceutical Phase 4
36
Ethambutol Approved Phase 2, Phase 3 74-55-5 3279 14052
37
Isoniazid Approved Phase 2, Phase 3 54-85-3 3767
38
Nevirapine Approved Phase 2, Phase 3 129618-40-2 4463
39
Rifampin Approved Phase 2, Phase 3 13292-46-1 5458213 5381226
40
Streptomycin Approved, Vet_approved Phase 2, Phase 3 57-92-1 19649
41
Fluconazole Approved Phase 3,Phase 2,Phase 1 86386-73-4 3365
42
Clotrimazole Approved, Vet_approved Phase 3 23593-75-1 2812
43
Flucytosine Approved Phase 2, Phase 3 2022-85-7 3366
44
Sertraline Approved Phase 3 79617-96-2 68617
45
Vitamin A Approved, Nutraceutical, Vet_approved Phase 3 11103-57-4, 68-26-8 445354
46 Antibiotics, Antitubercular Phase 2, Phase 3
47 Antimetabolites Phase 2, Phase 3
48 Antitubercular Agents Phase 2, Phase 3
49 Hypolipidemic Agents Phase 2, Phase 3
50 Lipid Regulating Agents Phase 2, Phase 3

Interventional clinical trials:

(show top 50) (show all 95)
id Name Status NCT ID Phase
1 Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali Completed NCT02286895 Phase 4
2 Cryptococcal Optimal ART Timing Trial Completed NCT01075152 Phase 4
3 Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection Completed NCT00371878 Phase 4
4 Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis Completed NCT00976040 Phase 4
5 Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults Completed NCT02062281 Phase 4
6 Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria Not yet recruiting NCT03087890 Phase 4
7 Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis Not yet recruiting NCT02686853 Phase 4
8 Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine Completed NCT01580033 Phase 3
9 Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children Completed NCT01428908 Phase 3
10 Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO) Completed NCT00495326 Phase 2, Phase 3
11 Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants Completed NCT00806195 Phase 3
12 A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults Completed NCT01466387 Phase 3
13 Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS Completed NCT00001017 Phase 3
14 Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers Completed NCT00483574 Phase 3
15 A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers Completed NCT00384397 Phase 3
16 Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants Completed NCT00161928 Phase 3
17 Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. Completed NCT00317187 Phase 3
18 Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. Completed NCT00317135 Phase 3
19 Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. Completed NCT00317161 Phase 3
20 Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects Completed NCT00369824 Phase 3
21 RotaTeq® and Meningococcus C Vaccine in Healthy Infants Completed NCT00443846 Phase 3
22 Persistency Study After Hib-CRM (Cross-Reacting Material)197 or Hib-TT (Tetanus Toxoid) Vaccines in Chinese Children Completed NCT02139228 Phase 3
23 A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents Completed NCT00518180 Phase 3
24 Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine Completed NCT01453348 Phase 3
25 Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) Completed NCT00000676 Phase 3
26 Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers Completed NCT00422292 Phase 3
27 Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults Completed NCT02123433 Phase 3
28 Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine. Recruiting NCT02699099 Phase 3
29 Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa Active, not recruiting NCT01715922 Phase 2, Phase 3
30 DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants Active, not recruiting NCT02274285 Phase 3
31 Cryptococcal Antigen Screening Plus Sertraline Not yet recruiting NCT03002012 Phase 3
32 Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months) Completed NCT00310856 Phase 2
33 Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination Completed NCT01650389 Phase 2
34 Dexamethasone in Cryptococcal Meningitis Completed NCT00000776 Phase 2
35 High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals Completed NCT00885703 Phase 1, Phase 2
36 Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis Completed NCT00012467 Phase 2
37 Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth Completed NCT00459316 Phase 1, Phase 2
38 A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17 Completed NCT01461993 Phase 2
39 Study Evaluating Safety & Immunogenicity of rLP2086 Vaccine in Adolescents Completed NCT00387725 Phase 2
40 A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDS Completed NCT00000975 Phase 2
41 Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL® Completed NCT00355121 Phase 2
42 Phase Ib Study of SC Milatuzumab in SLE Recruiting NCT01845740 Phase 1, Phase 2
43 Treatment With Tamoxifen in Cryptococcal Meningitis Not yet recruiting NCT03112031 Phase 2
44 Study of Anti-Malarials in Incomplete Lupus Erythematosus Not yet recruiting NCT03030118 Phase 2
45 Treatment of West Nile Virus With MGAWN1 Terminated NCT00927953 Phase 2
46 Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Children Completed NCT01406509 Phase 1
47 The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis Completed NCT00002316 Phase 1
48 SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy Completed NCT00000677 Phase 1
49 An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease Terminated NCT00091845 Phase 1
50 Long Term Outcomes of EV71 CNS Infection Unknown status NCT00172393

Search NIH Clinical Center for Viral Meningitis

Cochrane evidence based reviews: meningitis, viral

Genetic Tests for Viral Meningitis

Anatomical Context for Viral Meningitis

MalaCards organs/tissues related to Viral Meningitis:

39
Brain, Spinal Cord, T Cells, Testes, Neutrophil, B Cells, Liver

Publications for Viral Meningitis

Articles related to Viral Meningitis:

(show top 50) (show all 155)
id Title Authors Year
1
Cerebrospinal fluid metabolomic profiling in tuberculous and viral meningitis: Screening potential markers for differential diagnosis. ( 28063937 )
2017
2
Cerebrospinal fluid ferritin and albumin index: potential candidates for scoring system to differentiate between bacterial and viral meningitis in children. ( 26999689 )
2016
3
Meningitis retention syndrome: An unusual complication of viral meningitis. ( 27841204 )
2016
4
Hospital admissions for viral meningitis in children in England over five decades: a population-based observational study. ( 27527749 )
2016
5
The usefulness of serum delta neutrophil index for differentiating bacterial and viral meningitis in the emergency department. ( 27752624 )
2016
6
Predominance of enterovirus B and echovirus 30 as cause of viral meningitis in a UK population. ( 27367546 )
2016
7
Viral meningitis: epidemiology and diagnosis. ( 27527750 )
2016
8
Viral Meningitis Epidemics and a Single, Recent, Recombinant and Anthroponotic Origin of Swine Vesicular Disease Virus. ( 26508717 )
2015
9
Procalcitonin as a Serum Biomarker for Differentiation of Bacterial Meningitis From Viral Meningitis in Children: Evidence From a Meta-Analysis. ( 26378091 )
2015
10
Cerebral microbleeding in varicella-zoster viral meningitis: an early sign of vasculopathy? ( 24463624 )
2014
11
Restricted diffusion of the splenium of the corpus callosum in viral meningitis. ( 24707341 )
2014
12
Molecular characterisation of enteroviruses and clinical findings from a cluster of paediatric viral meningitis cases in Tshwane, South Africa 2010-2011. ( 25176522 )
2014
13
Time trends of viral meningitis among young adults in Israel: 1978-2012. ( 24463724 )
2014
14
Confirmed viral meningitis with normal CSF findings. ( 25035443 )
2014
15
Comparison of cytokine gene polymorphisms among Greek patients with invasive meningococcal disease or viral meningitis. ( 23378564 )
2013
16
Viral meningitis and encephalitis. ( 23981453 )
2013
17
Viral meningitis admitted to an infectious diseases hospital: a retrospective case series. ( 24340533 )
2013
18
Trends in the management of viral meningitis at United States children's hospitals. ( 23530164 )
2013
19
Underreporting of viral encephalitis and viral meningitis, Ireland, 2005-2008. ( 23965781 )
2013
20
Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi. ( 22798048 )
2013
21
Herpes zoster as a cause of viral meningitis in immunocompetent patients. ( 23307457 )
2013
22
Viral meningitis: which patients can be discharged from the emergency department? ( 22709622 )
2012
23
Acute bacterial and viral meningitis. ( 23221840 )
2012
24
Impact of polymerase chain reaction results on patient management during a viral meningitis outbreak in Tropical North Queensland. ( 22313560 )
2012
25
Lumbar puncture is not needed for all patients suspected to have viral meningitis. ( 22340799 )
2012
26
Vertebral artery dissection associated with viral meningitis. ( 22909191 )
2012
27
Clinical prediction rule for differentiating tuberculous from viral meningitis. ( 22507645 )
2012
28
Epidemics of viral meningitis caused by echovirus 6 and 30 in Korea in 2008. ( 22336050 )
2012
29
Vogt-Koyanagi-Harada syndrome: a rare but important differential diagnosis of viral meningitis. ( 21905951 )
2012
30
Performance of thirteen clinical rules to distinguish bacterial and presumed viral meningitis in Vietnamese children. ( 23209715 )
2012
31
Viral meningitis, active and reserve components, U.S. Armed Forces, 2002-2011. ( 22963254 )
2012
32
Patient Education Series. Viral meningitis in adults. ( 21403505 )
2011
33
Descriptive analysis of viral meningitis in a general hospital: differences in the characteristics between children and adults. ( 21349608 )
2011
34
A dural arteriovenous fistula in cavernous sinus developed from viral meningitis. ( 21748936 )
2011
35
Review of the etiologies of viral meningitis and encephalitis in a dengue endemic region. ( 21292281 )
2011
36
Cytokine and adhesion molecule expression evolves between the neutrophilic and lymphocytic phases of viral meningitis. ( 20626298 )
2010
37
Nondominant hemisphere encephalitis in patient with signs of viral meningitis, New York, USA. ( 19751606 )
2009
38
Myelomonocytic cell recruitment causes fatal CNS vascular injury during acute viral meningitis. ( 19011611 )
2009
39
CSF lactate level: a useful diagnostic tool to differentiate acute bacterial and viral meningitis. ( 19757692 )
2009
40
Secondary SUNCT syndrome caused by viral meningitis. ( 19444540 )
2009
41
Temporary divergence paralysis in viral meningitis. ( 18562842 )
2008
42
Acute and recurrent viral meningitis. ( 18579020 )
2008
43
Viral meningitis. ( 18174598 )
2008
44
Diagnosing viral meningitis: Other important diagnoses must be excluded. ( 18202044 )
2008
45
Clinical features of viral meningitis in adults: significant differences in cerebrospinal fluid findings among herpes simplex virus, varicella zoster virus, and enterovirus infections. ( 18680414 )
2008
46
A new parameter in the differential diagnosis of bacterial and viral meningitis. ( 21063298 )
2008
47
Rarity of bacterial and viral meningitis in areas of Western Greece with fewer than 2,000 inhabitants. ( 18219135 )
2008
48
[Differential diagnosis of bacterial and viral meningitis in childhood acute meningitis: a statistical model]. ( 17427553 )
2007
49
Diagnosis and treatment of viral meningitis. ( 23218107 )
2007
50
Sudden death in toddlers with viral meningitis, massive cerebral edema, and neurogenic pulmonary edema and hemorrhage: report of two cases. ( 18001157 )
2007

Variations for Viral Meningitis

Expression for Viral Meningitis

Search GEO for disease gene expression data for Viral Meningitis.

Pathways for Viral Meningitis

Pathways related to Viral Meningitis according to GeneCards Suite gene sharing:

(show all 42)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.79 CCL2 CCL5 CD14 CRP CXCL10 CXCL8
2
Show member pathways
13.55 CCL2 CCL5 CD14 CXCL10 CXCL8 IFNG
3
Show member pathways
13.44 CCL2 CCL5 CXCL8 IFNG IL16 IL6
4
Show member pathways
13.32 CCL2 CCL5 CXCL10 CXCL8 IL16 IL6
5
Show member pathways
13.26 CCL2 CCL5 CXCL10 CXCL8 IFNG IL16
6
Show member pathways
13.2 CCL2 CCL5 CXCL10 CXCL8 IL16 IL6
7
Show member pathways
12.9 CCL2 CCL5 CD14 CXCL8 IL6
8
Show member pathways
12.69 CCL2 CCL5 CD14 CXCL10 CXCL8 IFNG
9
Show member pathways
12.68 CCL2 CCL5 CXCL10 CXCL8 IFNG IL6
10
Show member pathways
12.66 CCL5 CXCL10 CXCL8 IFNG IL6
11
Show member pathways
12.51 CCL2 CD14 IFNG IL6
12 12.46 CCL2 CCL5 CXCL10 IFNG
13
Show member pathways
12.23 CCL2 CCL5 CRP IFNG IL6
14
Show member pathways
12.21 CD14 CXCL8 IFNG IL6
15
Show member pathways
12.21 CCL2 CXCL10 CXCL8 IFNG IL6
16
Show member pathways
12.09 CXCL8 IFNG IL16 IL6
17
Show member pathways
12.05 CD14 CXCL10 CXCL8 IFNG IL6
18
Show member pathways
11.97 CCL2 CCL5 CXCL10 CXCL8
19 11.93 CD14 IFNG IL6
20 11.91 CCL2 CXCL8 IL6
21 11.89 CCL2 CCL5 CXCL10 IL6
22 11.88 CXCL8 IFNG IL6
23 11.84 CCL2 CXCL8 IL6
24 11.83 CD14 CXCL8 IFNG IL6
25
Show member pathways
11.81 CD14 CXCL8 IL6
26 11.8 CCL2 CXCL10 CXCL8 IFNG IL6
27 11.76 CD14 CXCL8 IFNG IL6
28 11.75 CXCL8 IFNG IL6
29 11.71 CD14 IFNG IL6
30 11.7 CD14 CXCL8 IL6
31
Show member pathways
11.62 CXCL8 IFNG IL6
32 11.61 CCL2 CCL5 CXCL8 IFNG IL6
33 11.55 CXCL8 IFNG IL6
34 11.55 CD14 CXCL8 IL6
35 11.4 CCL2 CXCL8 IFNG IL6
36 11.31 CCL2 CXCL8 IL6
37 11.15 CCL2 CCL5 CXCL8 IL6 SERPINA1
38 11.14 CCL2 IFNG TIMP2
39 11.07 CCL5 CXCL8
40 10.99 CRP CXCL8 IL6
41 10.86 CCL2 CCL5 CXCL10 CXCL8 IL16 IL6
42 10.71 CCL2 CCL5 CXCL10 CXCL8 IL6

GO Terms for Viral Meningitis

Cellular components related to Viral Meningitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.7 CCL2 CCL5 CD14 CRP CXCL10 CXCL8
2 external side of plasma membrane GO:0009897 9.55 ADA CD14 CXCL10 IFNG IL6
3 extracellular space GO:0005615 9.4 ADA CCL2 CCL5 CD14 CRP CXCL10

Biological processes related to Viral Meningitis according to GeneCards Suite gene sharing:

(show all 47)
id Name GO ID Score Top Affiliating Genes
1 cell surface receptor signaling pathway GO:0007166 9.94 CCL2 CD14 CXCL10 IFNG
2 response to lipopolysaccharide GO:0032496 9.91 CCL2 CD14 CXCL10 IL6
3 aging GO:0007568 9.88 ADA CCL2 IL6 TIMP2
4 response to drug GO:0042493 9.88 ADA CCL2 IFNG IL6 TIMP2
5 response to virus GO:0009615 9.86 CCL5 CXCL10 IFNG
6 positive regulation of neuron differentiation GO:0045666 9.83 IFNG IL6 TIMP2
7 cell chemotaxis GO:0060326 9.81 CCL2 CCL5 CXCL10
8 positive regulation of T cell proliferation GO:0042102 9.81 CCL5 IFNG IL6
9 response to cytokine GO:0034097 9.8 CCL5 IL6 TIMP2
10 humoral immune response GO:0006959 9.8 CCL2 IFNG IL6
11 response to heat GO:0009408 9.79 CCL2 CD14 IL6
12 positive regulation of cell adhesion GO:0045785 9.77 CCL2 CCL5 IFNG
13 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.77 CCL5 IFNG IL6
14 positive regulation of tumor necrosis factor production GO:0032760 9.76 CCL2 CD14 IFNG
15 cellular response to tumor necrosis factor GO:0071356 9.76 CCL2 CCL5 CXCL8 IL6
16 monocyte chemotaxis GO:0002548 9.74 CCL2 CCL5 IL6
17 acute-phase response GO:0006953 9.72 CRP IL6 SERPINA1
18 response to bacterium GO:0009617 9.71 CCL2 CD14 IL6
19 cellular response to interleukin-1 GO:0071347 9.71 CCL2 CCL5 CXCL8 IL6
20 positive regulation of T cell activation GO:0050870 9.7 ADA CCL2
21 defense response to protozoan GO:0042832 9.7 IFNG IL6
22 lipopolysaccharide-mediated signaling pathway GO:0031663 9.7 CCL2 CCL5 CD14
23 immune response GO:0006955 9.7 CCL2 CCL5 CXCL10 CXCL8 IFNG IL16
24 positive regulation of JAK-STAT cascade GO:0046427 9.69 CCL5 IL6
25 embryonic digestive tract development GO:0048566 9.69 ADA CXCL8
26 positive regulation of macrophage chemotaxis GO:0010759 9.69 CCL2 CCL5
27 cellular response to fibroblast growth factor stimulus GO:0044344 9.69 CCL2 CCL5 CXCL8
28 induction of positive chemotaxis GO:0050930 9.68 CXCL8 IL16
29 macrophage chemotaxis GO:0048246 9.68 CCL2 CCL5
30 positive regulation of T cell migration GO:2000406 9.68 CCL5 CXCL10
31 response to molecule of bacterial origin GO:0002237 9.67 CD14 CXCL8
32 PERK-mediated unfolded protein response GO:0036499 9.67 CCL2 CXCL8
33 positive regulation of protein import into nucleus, translocation GO:0033160 9.67 IFNG IL6
34 response to tumor necrosis factor GO:0034612 9.67 CCL2 CCL5 CD14
35 chemokine-mediated signaling pathway GO:0070098 9.67 CCL2 CCL5 CXCL10 CXCL8
36 negative regulation of G-protein coupled receptor protein signaling pathway GO:0045744 9.66 CCL5 CXCL8
37 response to auditory stimulus GO:0010996 9.66 CXCL10 IL6
38 negative regulation of lipid storage GO:0010888 9.65 CRP IL6
39 neutrophil activation GO:0042119 9.65 CCL5 CXCL8
40 chemotaxis GO:0006935 9.65 CCL2 CCL5 CXCL10 CXCL8 IL16
41 regulation of vascular endothelial growth factor production GO:0010574 9.62 CCL2 IL6
42 neutrophil chemotaxis GO:0030593 9.62 CCL2 CCL5 CXCL8 IFNG
43 positive regulation of monocyte chemotaxis GO:0090026 9.61 CCL2 CCL5 CXCL10
44 neutrophil apoptotic process GO:0001781 9.56 IFNG IL6
45 inflammatory response GO:0006954 9.5 CCL2 CCL5 CD14 CRP CXCL10 CXCL8
46 cellular response to lipopolysaccharide GO:0071222 9.1 CCL2 CD14 CXCL10 CXCL8 IFNG IL6
47 negative regulation of cell proliferation GO:0008285 10 CXCL8 IFNG IL6 TIMP2

Molecular functions related to Viral Meningitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 chemokine activity GO:0008009 9.26 CCL2 CCL5 CXCL10 CXCL8
2 cytokine activity GO:0005125 9.17 CCL2 CCL5 CXCL10 CXCL8 IFNG IL16

Sources for Viral Meningitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....